US Patent Issued to AURIGENE ONCOLOGY on March 3 for "1,2,4-oxadiazole compounds as inhibitors of CD47 signalling pathways" (Indian Inventors)

ALEXANDRIA, Va., March 3 -- United States Patent no. 12,565,515, issued on March 3, was assigned to AURIGENE ONCOLOGY Ltd. (Bangalore, India).

"1,2,4-oxadiazole compounds as inhibitors of CD47 signalling pathways" was invented by Pottayil Govindan Nair Sasikumar (Bangalore, India), Muralidhara Ramachandra (Bangalore, India), Seetharamaiah Setty Sudarshan Naremaddepalli (Bangalore, India) and Chennakrishnareddy Gundala (Bangalore, India).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to compounds of formula (I), compositions, methods and uses involving the said formula (I) that inhibit CD47 signaling pathway. The present invention also relates to methods of making such compounds a...